IP Library Granted Patent US 8,647,672
Granted Patent B2
US 8,647,672 · App. 13/499,342 · Granted Feb 11, 2014

Method for producing a cross-linked polyacrylate polymer implant material

Inventors: Oliver Bielenstein (Berlin, DE); Stefan Deusser (Kahl a. Main, DE); Christoph Sattig (Dieburg, DE); Volker Stirnal (Dieburg, DE)
Assignee: AAP Biomaterials GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,647,672
App. No.
13/499,342
Granted
Feb 11, 2014
Kind
B2
Abstract

The invention relates to an implant material comprising a polymer which is partially cross-linked by means of a metal acrylate salt.

Claims (16)

1. A method of producing an implant material, comprising the step of cross-linking a polymer with a polymerizable metal salt by dissolving said polymerizable metal salt in an acrylic monomer to produce a cross-linked polyacrylate polymer via polymerization.

2. The method of claim 1 , wherein said polymerizable metal salt is a metal acrylate.

3. The method of claim 2 , wherein said metal acrylate includes a metal selected from the group consisting of Ba, Sr, Mg, Zn, Sn, Cu, Zr, Fe, Cr, Mo, Mn, Co, Ti, and any combinations thereof.

4. The method of claim 1 , wherein said polymerizable metal salt is an acrylate having at least one four-valent central atom.

5. The method of claim 1 , wherein during said producing step, 10 to 50% of the polymerizable metal salt is used.

6. The method of claim 1 , further comprising the steps of:

producing partially cross-linked polymer particles of said partially cross-linked polymer;

partially dissolving or swelling said polymer particles in a monomer; and

polymerizing the implant material from said monomer, wherein said polymer particles are cross-linked with the partially cross-linked polymer.

7. The method of claim 1 , further comprising the step of adding said partially cross-linked polymer to a solvent, wherein portions of said partially cross-linked polymer that are not cross-linked are at least partially dissolved out and a porous structure is formed.

8. The method of claim 7 , further characterized in that between 20 and 80% of the volume of the implant material is dissolved out.

9. The method of claim 7 , wherein said porous structure is used as a support for an active substance.

10. The method of claim 1 , further 30 comprising the step of adding an initiator and an accelerator during said producing step.

11. The method of claim 10 , wherein said initiator is dibenzoyl peroxide, and said accelerator is dimethyl p-toluidine.

12. The method of claim 1 , wherein said acrylic monomer is a methacrylate.

13. The method of claim 1 , wherein said acrylic monomer is a methacrylic acid.

Assignments (2)
CHANGE OF NAME Recorded Sep 20, 2018
From: AAP BIOMATERIALS GMBH
To: OSARTIS GMBH
Reel/Frame 047115/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2012
From: BIELENSTEIN, OLIVER; DEUSSER, STEFAN; SATTIG, CHRISTOPH; STIRNAL, VOLKER
To: AAP BIOMATERIALS GMBH
Reel/Frame 028339/0944 →
Priority Claims (1)
DE 10 2009 043 551 · Sep 30, 2009 · national
Continuity (1)
Related Publication 20120302648A1 · Nov 29, 2012